The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12874-023-02022-3
PubMed Identifier: 37667204
Publication URI: http://europepmc.org/abstract/MED/37667204
Type: Journal Article/Review
Volume: 23
Parent Publication: BMC medical research methodology
Issue: 1
ISSN: 1471-2288